EDII Institutional Repository
Development of Receptors to Optimally Retarget Human T-cells to MHe-restricted Tumor or Viral Antigens.
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Gujarat State Biotechnology Mission | |
| dc.date.accessioned | 2019-07-14T08:29:06Z | |
| dc.date.available | 2019-07-14T08:29:06Z | |
| dc.date.issued | 2006 | |
| dc.identifier.uri | http://library.ediindia.ac.in:8181/xmlui//handle/123456789/8966 | |
| dc.language.iso | en | en_US |
| dc.publisher | Gujarat Department of Science and Technology | en_US |
| dc.subject | T-cell receptors (TCR) | en_US |
| dc.subject | CD3 | en_US |
| dc.subject | MAGE-A1 and gp100 | en_US |
| dc.subject | Epstein-Barr viral antigens EBNA-3A1B and BMLF-1 | en_US |
| dc.subject | cancer immunotherapy | en_US |
| dc.subject | Gene Transfer & Therapeutics | en_US |
| dc.subject | Pharmaceutical and Healthcare | en_US |
| dc.subject | GSBTM | en_US |
| dc.title | Development of Receptors to Optimally Retarget Human T-cells to MHe-restricted Tumor or Viral Antigens. | en_US |
| dc.type | Other | en_US |
